cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Hookipa Pharma Inc
38 own
75 watching
Current Price
$0.64
$-0.02
(-2.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
60.19M
52-Week High
52-Week High
2.05000
52-Week Low
52-Week Low
0.41000
Average Volume
Average Volume
0.73M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
115.2084
iconMarket Capitalization60.19M
icon52-Week High2.05000
icon52-Week Low0.41000
iconAverage Volume0.73M
iconDividend Yield--
iconP/E Ratio115.2084
What does the Hookipa Pharma Inc do?
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
Read More
How much money does Hookipa Pharma Inc make?
News & Events about Hookipa Pharma Inc.
Globe Newswire
8 months ago
NEW YORK and VIENNA, Austria, June 10, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that the Compensation Committee of the Companys Board of Directors ...
PR Newswire
10 months ago
Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? Thinking about buying stock in Hookipa Pharma, Ford Motor, JPMorgan, Spotify Technology, or Wynn Resorts? PR Newswire NEW YORK, May 1, 2023 NEW YORK, May 1, 2023 /PRNewswire...
Globe Newswire
10 months ago
NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that a Trial in Progress poster on its ongoing Phase 1/2 clinical study (...
Globe Newswire
11 months ago
NEW YORK and VIENNA, March 08, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, HOOKIPA), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that it will release fourth quarter and full year 2022 financial results before ...
Frequently Asked Questions
Frequently Asked Questions
What is Hookipa Pharma Inc share price today?
plus_minus_icon
Can Indians buy Hookipa Pharma Inc shares?
plus_minus_icon
How can I buy Hookipa Pharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Hookipa Pharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Hookipa Pharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Hookipa Pharma Inc?
plus_minus_icon
What is today’s market capitalisation of Hookipa Pharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Hookipa Pharma Inc?
plus_minus_icon
What percentage is Hookipa Pharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Hookipa Pharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.64
$-0.02
(-2.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00